Chemistry & Biochemistry

Permanent URI for this communityhttps://scholarworks.montana.edu/handle/1/42

The Department of Chemistry and Biochemistry offers research-oriented programs culminating in the Doctor of Philosophy degree. The faculty in the department have expertise over a broad range of specialty areas including synthesis, structure, spectroscopy, and mechanism. In each of these fields, the strength of the department has been recognized at the international level.

Browse

Filters

20241

Settings

Author: search.filters.author.Welhaven, Hope D.Subject: search.filters.subject.Biomarkers

Search Results

Now showing 1 - 1 of 1
  • Thumbnail Image
    Item
    Osteoarthritis Year in Review 2024: Molecular biomarkers of osteoarthritis
    (Elsevier BV, 2024-10) Welhaven, Hope D.; Welfley, Avery H.; June, Ronald K.
    Objective. To provide a comprehensive and insightful summary of studies on molecular biomarkers at the gene, protein, and metabolite levels across different sample types and joints affected by osteoarthritis (OA). Methods. A literature search using the PubMed database for publications on OA biomarkers published between April 1, 2023 and April 30, 2024 was performed. Publications were then screened, examined at length, and summarized in a narrative review. Results. Out of the 364 papers initially identified, 44 publications met inclusion criteria, were relevant to OA, and were further examined for data extraction and discussion. These studies included 1 genomic analysis, 22 on protein markers, 6 on metabolite markers, 9 on inflammatory mediators, and 6 integrating multiple molecular levels. Conclusions. Significant advancements have been made in identifying molecular biomarkers for OA, encompassing various joints, sample types, and molecular levels. Despite this progress, gaps remain, particularly in the need for validation, larger sample sizes, the integration of more clinical data, and consideration of covariates. For early detection and improved treatment of OA, continued efforts in biomarker identification are needed. This effort should seek to identify effective biomarkers that advance early detection, support prevention, evaluate interventions, and improve patient outcomes.
Copyright (c) 2002-2022, LYRASIS. All rights reserved.